We are live on
!
Find out more
National Bank of Canada Portfolio holdings
AUM
$140B
1-Year Est. Return
46.34%
This Fund
S&P 500
This Quarter
Est. Return
+12.88%
1 Year Est. Return
+46.34%
3 Year Est. Return
+120.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62.6B
AUM Growth
-$3.11B
(-4.7%)
Cap. Flow
-$8.57B
Cap. Flow
% of AUM
-13.7%
Top 10 Holdings %
Top 10 Hldgs %
23.97%
Holding
2,962
New
190
Increased
862
Reduced
990
Closed
256
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$739M |
| 2 |
Apple
AAPL
|
+$436M |
| 3 |
Broadcom
AVGO
|
+$405M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$305M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.04B |
| 2 |
NVIDIA
NVDA
|
+$709M |
| 3 |
Advanced Micro Devices
AMD
|
+$687M |
| 4 |
Toronto Dominion Bank
TD
|
+$647M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$483M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.1% |
| 2 | Financials | 18.09% |
| 3 | Healthcare | 6.87% |
| 4 | Consumer Discretionary | 6.64% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Rollins
ROL
$17.4B
| $3.2M | 0.01% |
73,973
+13,918
| +23% | +$542K |
|
902
OneMain Financial
OMF
$7.51B
| $3.16M | 0.01% |
64,066
+26,100
| +69% | +$1.06M |
|
903
ROBO Global Robotics & Automation Index ETF
ROBO
$2.13B
| $3.14M | 0.01% |
56,154
+178
| +0.3% | +$9.08K |
|
904
AptarGroup
ATR
$8.43B
| $3.11M | 0.01% |
25,348
+24,974
| +6,678% | +$3.14M |
|
905
Brown-Forman Class B
BF.B
$12.9B
| $3.1M | 0.01% |
54,486
+3,670
| +7% | +$210K |
|
906
MGM Resorts International
MGM
$11.1B
| $3.09M | ﹤0.01% |
67,934
+4,203
| +7% | +$165K |
|
|
IPG
907
DELISTED
Interpublic Group of Companies
IPG
| $3.09M | ﹤0.01% |
93,283
+7,258
| +8% | +$219K |
|
908
PUT
Nano X Imaging
NNOX
$73.2M
| $3.08M | ﹤0.01% |
4,770
+17
| +0.4% | +$106 |
|
909
Everest Group
EG
$14B
| $3.08M | ﹤0.01% |
8,517
+6,860
| +414% | +$2.66M |
|
910
Vanguard Industrials ETF
VIS
$8.5B
| $3.06M | ﹤0.01% |
14,015
+126
| +0.9% | +$25.4K |
|
911
iShares MSCI Agriculture Producers ETF
VEGI
$147M
| $3.06M | ﹤0.01% |
80,080
-196
| -0.2% | -$7.26K |
|
912
Darling Ingredients
DAR
$10.4B
| $3.05M | ﹤0.01% |
61,103
-1,755
| -3% | -$79.7K |
|
913
Neurocrine Biosciences
NBIX
$15.3B
| $3.03M | ﹤0.01% |
22,966
+21,964
| +2,192% | +$2.53M |
|
914
CarMax
KMX
$8.52B
| $3.03M | ﹤0.01% |
39,701
-27,789
| -41% | -$1.87M |
|
915
AES
AES
$10.5B
| $3.02M | ﹤0.01% |
156,243
-55,588
| -26% | -$904K |
|
916
AXIS Capital
AXS
$7.3B
| $2.96M | ﹤0.01% |
53,600
-41,222
| -43% | -$2.29M |
|
917
Henry Schein
HSIC
$10B
| $2.96M | ﹤0.01% |
39,153
+1,950
| +5% | +$136K |
|
918
Nutanix
NTNX
$18.4B
| $2.93M | ﹤0.01% |
+63,967
| New | +$2.59M |
|
|
LEV
919
DELISTED
The Lion Electric Company
LEV
| $2.92M | ﹤0.01% |
1,693,293
+36,981
| +2% | +$64.3K |
|
920
Petrobras
PBR
$115B
| $2.92M | ﹤0.01% |
182,471
-20,556
| -10% | -$315K |
|
921
iShares Latin America 40 ETF
ILF
$3.69B
| $2.9M | ﹤0.01% |
101,123
-10,508
| -9% | -$281K |
|
922
PUT
QuantumScape Corp
QS
$3.79B
| $2.84M | ﹤0.01% |
4,240
-3,947
| -48% | -$24.9K |
|
923
Incyte
INCY
$24.4B
| $2.84M | ﹤0.01% |
43,394
-84,795
| -66% | -$4.8M |
|
924
PUT
Blink Charging
BLNK
$87.1M
| $2.84M | ﹤0.01% |
8,957
-6,852
| -43% | -$21.4K |
|
925
Bio-Techne
TECH
$11.2B
| $2.83M | ﹤0.01% |
36,942
+3,312
| +10% | +$218K |
|
Similar funds
National Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, National Bank of Canada held 2,962 positions worth $62.6B, down 4.7% from $65.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
National Bank of Canada withdrew a net $8.57B in Q4 2023, closing 256 positions and reducing 990 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, National Bank of Canada opened a new position in Mirati Therapeutics, Inc. Common Stock worth $28M.
- National Bank of Canada's largest Q4 2023 buy was Mirati Therapeutics, Inc. Common Stock: 473,500 shares worth $28M.
- National Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $739M increase.
- National Bank of Canada's biggest Q4 2023 reduction was Amazon, cutting an estimated $1.04B.
- National Bank of Canada fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $102M.
- National Bank of Canada's ten largest holdings make up 24% of its $62.6B portfolio in Q4 2023.
- National Bank of Canada opened 190 new positions and closed 256 in Q4 2023.
- National Bank of Canada's portfolio value fell 4.7% quarter-over-quarter to $62.6B.
Based on National Bank of Canada's 13F filing for Q4 2023, filed 6 Feb 2024.